Aeternum Health (AETN) Common Equity (2011 - 2026)

Aeternum Health (AETN) has 16 years of Common Equity data on file, last reported at -$2.1 million in Q1 2026.

• Common Equity for Q1 2026 came in at -$2.1 million, down 24.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 24.53% YoY), and the FY2025 annual result was -$2.0 million, down 19.26% from the prior year.
• Common Equity slipped to -$2.1 million in Q1 2026 per AETN's latest filing, from -$2.0 million in the prior quarter.
• Over five years, Common Equity peaked at -$846521.0 in Q1 2023 and troughed at -$2.1 million in Q1 2026.
• A 5-year average of -$1.5 million and a median of -$1.5 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2023: Common Equity sank 623.27% in 2022, then surged 46.96% in 2023.
• A 5-year view of Common Equity shows it stood at -$1.2 million in 2022, then rose by 2.52% to -$1.2 million in 2023, then plunged by 41.53% to -$1.7 million in 2024, then dropped by 19.26% to -$2.0 million in 2025, then declined by 3.16% to -$2.1 million in 2026.
• Business Quant data shows AETN's Common Equity at -$2.1 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.9 million in Q3 2025.